A critical review of control strategies with regard to meningococcal meningitis epidemics in Sub-Saharan African countries;Revue critique des stratégies de contrôle des épidémies de méningite à méningocoque en Afrique Sub-Saharienne

Bulletin de la Societe de Pathologie Exotique

Volumn 95, Issue 1, 2002, Pages 37-44

  Chippaux, J P ^a   Debois, H ^b   Saliou, P ^b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b SANOFI PASTEUR   (France)

Author keywords

Control strategy; Meningitis; Neisseria; Sub Saharan Africa; Vaccine

Indexed keywords

MENINGITIS VACCINE; POLYSACCHARIDE VACCINE;

AFRICA; DRUG COST; DRUG EFFICACY; EPIDEMIC MENINGITIS; EVALUATION; HUMAN; IMMUNOGENICITY; INCIDENCE; INFECTION CONTROL; REVIEW; TREATMENT OUTCOME; VACCINATION; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; DISEASE OUTBREAKS; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE; WORLD HEALTH ORGANIZATION;

EID: 0036523260     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Blakesbrough IS, Greenwood BM, Whittle HC, Bradley AK & Gilles HM - The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis, 1982, 146, 626-636.
2. Bovier PA, Wyss K & Au HJ - A cost-effectiveness analysis of vaccination strategies against N. meningitidis meningitis in sub-Saharan African countries. Soc Sci Med, 1999, 48, 1205-1220.
3. Campagne G, Chippaux JP, Djibo S, Issa O & Garba A - Epidémiologie et contrôle des méningites bactériennes chez les nourrissons à Niamey. Bull Soc Pathol Exot, 1999, 92, 118-122.
4. Campagne G, Djibo S, Schuchat A, Ousseini A, Cisse L & Chippaux JP - Epidemiology of bacterial meningitis in Niamey, Niger, 1981-1996. Bull OMS, 1999, 77, 499-508.
5. Campagne G, Garba A, Fabre P, Schuchat A, Ryall R et al.- Safety and immunogenicity of three doses of a Neisseria meningitidis A+C diphtheria conjugate vaccine in infants from Niger. Ped Infect Dis J, 1999, 19, 144-150.
6. Ceesay SJ, Allen SJ, Menon A, Todd JE, Cham K et al.- Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infec Dis, 1993, 167, 1212-1216.
7. Chabalier F De, Chippaux JP & Massougbodji A - Meningococcal immunisation in Ghana. Lancet, 2000, 355, 2252-2253.
8. Chabalier F De, Djingarey MH, Hassane A & Chippaux JP - Meningitis seasonal pattern in Africa and detection of epidemics: A retrospective study in Niger, 1990-98. Trans R Soc Trop Med Hyg, 2000, 94, 664-668.
9. Chabalier F De, Hassane A & Chippaux JP - Evaluation of surveillance thresholds for prediction of meningitis epidemics using ongoing surveillance data at the district level, in Niger. Trans R Soc Trop Med Hyg, 2000, 94, 251-252.
10. Chippaux JP, Campagne G, Djibo S, Hassane A, Kanta I & Cisse L - Possible impediment of preventive immunisation on the onset of meningococcal epidemics in the African meningitis belt. Ann Trop Med Parasitol, 1999, 93, 505-510.
11. Chippaux JP, Soula G, Campagne G, Rey M et al. - Optimiser la riposte aux épidémies de méningite à méningocoque: Rapport d'un atelier d'experts au CERMES de Niamey du 12 au 14 janvier 1998. Cahiers Santé, 1998, 8, 245-248.
12. Da Silva A, Parent Du Chatelet I, Gaye AB, Dompnier JP & Seck I - Evaluation microéconomique des coûts opérationnels d'une campagne de masse préventive contre la méningite à méningocoque associant une vaccination contre la fièvre jaune au Sénégal en 1997: Méthode et résultats. Cahiers Santé, 2001, sous presse.
13. De Wals P, Dionne M, Douville-Fradet M, Boulianne N, Drapeau J & De Serres G - Impact of a mass immunization campaign against serogroup C meningococcus in the Province of Quebec, Canada. Bull OMS, 1996, 74, 407-411.
14. Diallo A, Etard JF & Chippaux JP - Buerst of Neisseria meningitidis A outbreak after a 15 years free period. Am J Trop Med Hyg, 2001, 65, S295.
15. Etienne J, Sperber G, Adamou A & Picq JJ - Notes épidémiologiques: Les méningites à méningocoques du sérogroupe X à Niamey (Niger). Méd Trop, 1990, 50, 227-229.
16. Gold R, Goldschneider I, Lepow ML, Draper TF & Randolph M - Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis, 1978, 137, 112-121.
17. Gold R, Lepow ML, Goldschneider I & Gotschlich EC - Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis. J Infect Dis, 1977, 136, S31-S35.
18. Goldschneider I, Gotschlich EC & Artenstein MS - Human immunity to the meningococcus. I. The role of antibodies. J Exp Med, 1969, 129, 1307-1326.
19. Goldschneider I, Gotschlich EC & Artenstein MS - Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med, 1969, 129, 1327-1348.
20. Gotschlich EC, Rey M, Triau R & Sparks KJ - Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest, 1972, 51, 89-96.
21. Greenwood BM - The epidemiology of acute bacterial meningitis in tropical Africa. In: Williams JD & Burnie J (Eds), Bacterial Meningitis, Academic Press, Londres, 1987, pp. 61-91.
22. Greenwood BM, Bradley AK, Blakebrough IS, Whittle HC, Marshall TF De & Gilles HM - The immune response to a meningococcal polysaccharide vaccine in an African village. Trans R Soc Trop Med Hyg, 1980, 74, 340-346.
23. Greenwood BM, Hassan-King M & Whittle HC - Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Brit Med J, 1978, 277, 1317-1319.
24. Greenwood BM & Wali SS - Control of meningococcal infection in the African meningitis belt by selective vaccination. Lancet, 1980, i, 729-732.
25. Greenwood BM, Whittle HC, Bradley AK, Fayet MT & Gilles HM - The duration of the antibody response to meningococcal vaccination in an African village. Trans R Soc Trop Med Hyg, 1980, 74, 756-760.
26. Hassan J, Massougbodji A, Chippaux JP, Massit B & Josse R - Meningococcal immunisation and protection from epidemics. Lancet, 1998, 352, 407-408.
27. Hassan-King MK, Wall RA & Greenwood BM - Meningococcal carriage, meningococcal disease and vaccination. J Infect, 1988, 16, 55-59.
28. Higham JH - Meningococcal vaccine in Sub Saharan Africa. Lancet, 1997, 350, 1707-1708.
29. Kaninda AV, Varaine F, Henkens M & Paquet C - Meningococcal vaccine in Sub-Saharan Africa. Lancet, 1997, 350, 1708.
30. Koumare B, Konate M, Cisse M & Doumbia T - Etude du portage rhinopharyngé de Neisseria meningitidis sérogroupe C dans la collectivité autour des patients au Mali. A propos de 1033 sujets prélevés. Bull Soc Pathol Exot, 1994, 87, 148-151.
31. Kriz P, Vlckova J & Bobak M - Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic. Epidemiol Infect, 1995, 115, 411-418.
32. Kwara A, Adegbola RA, Corrah PT, Weber M, Achtman M et al.- Meningitis caused by a serogroup W135 clone of the ET-37 complex of Neisseria meningitis in West Africa. Trop Med Intern Health, 1998, 3, 742-746.
33. Lapeysonnie L - La méningite cérébro-spinale en Afrique. Bull OMS, 1963, 28, 1-114.
34. Lewis R, Varaine F, Belanger F, Nathan N & Diarra L - Control of meningococcal disease in west Africa. Lancet, 2000, 355, 1185-1186.
35. McDamien D, Boelaert M, Van Damme W & Van der Stuyft P - Meningococcal immunisation in Ghana. Lancet, 2000, 355, 2252.
36. Miller MA, Wenger J, Rosenstein N & Perkins B - Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa. Pediatr Infect Dis J, 1999, 12, 1051-1059.
37. Moore PS, Plikaytis BD, Bolan GA, Oxtoby MJ, Yada A et al.- Detection of meningitis epidemics in Africa: A population-based analysis. Int J Epidemiol, 1992, 21, 155-162.
38. Nieminen T, Kayhty H & Kantele A - Circulating antibody secreting cells and humoral antibody response after parenteral immunization with a meningococcal polysaccharide vaccine. Scand J Infect Dis, 1996, 28, 53-58.
39. Obaro S - Control of meningococcal disease in west Africa. Lancet, 355, 2000, 1184-1185.
40. Parent Du Chatelet I, Gessner BD & Silva A Da - Comparison of cost-effectiveness of preventive and reactive mass immunization campaigns against meningococcal meningitis in West Africa: A theoretical modeling analysis. Vaccine, 2001, 19, 3420-3431.
41. Peltola H, Kataja JM & Mäkelä PH - Shift in the age distribution of meningococcal disease as predictor of an epidemic? Lancet, 1982, ii, 595-597.
42. Peltola H, Mäkelä PH, Käyhty H, Jousimies H, Herva E et al.- Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. New Engl J Med, 1977, 297, 686-691.
43. Perkins BA, Broome CV, Rosenstein NE, Schuchat A & Reingold AL - Meningococcal vaccine in Sub-Saharan Africa. Lancet, 1997, 350, 1708.
44. Poolman JT - Nouveaux vaccins méningococciques. Ann Inst Pasteur Actualités, 1994, 5, 157-160.
45. Reingold AL, Broome CV, Hightower A, Ajello GW, Bolan GA et al.- Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet, 1987, 2, 114-118.
46. Riou JY, Djibo S, Sangare L, Lombart JP, Fagot P et al.- A predictable comeback: The second pandemic of infections due to Neisseria meningitidis serogroup A subgroup III-1 in Africa in 1995. Bull OMS, 1996, 74, 181-187
47. Robbins JB, Schneerson R & Gotschlich EC - A rebuttal: Epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine. Pediatr Infect Dis J, 2000, 19, 945-953.
48. Robbins JB, Towne DW, Gotschlich EC & Schneerson R - "love's labours lost": Failure to implement mass vaccination against group A meningoccoccal meningitis in sub-Saharan Africa. Lancet, 1997, 350, 880-882.
49. Saliou P, Rey JL & Stoeckel P - Une nouvelle stratégie de lutte contre les épidémies de méningites à méningocoques en Afrique Sahélienne. Bull Soc Pathol Exot, 1978, 71, 34-45.
50. Saliou P, Stoeckel P, Lafaye A & Rey JL - Essais controlés du vaccin anti-méningococcique polysaccharidique A en Afrique de l'Ouest Sahélienne (Haute Volta et Mali). Dev Biol Stand, 1978, 41, 97-108.
51. Salleras L, Dominguez A & Prats G - Control of serogroup C meningococcal meningitis by mass vaccination in Catalonia (Spain). Vaccine, 1999, 17 Suppl 3, S56-S60.
52. Smith AW, Bradley AK, Wall RA, McPherson B, Secka A et al.- Sequelae of epidemic meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg, 1988, 82, 312-320.
53. Spiegel A, Greindl Y, Lippeveld T, Decam C, Granga D et al.- Effet de deux stratégies de vaccination sur l'évolution de l'épidémie de méningite à méningocoque A survenue à N'Djamena (Tchad) en 1988. Bull OMS, 1993, 71, 311-315.
54. Spiegel A, Quenel P, Sperber G & Meyran M - Evaluation de l'efficacité de la stratégie de vaccination systématique antiméningococcique chez les appelés de l'armée française. Cahiers Santé, 1996, 6, 383-388.
55. Stephens DS - Uncloaking the meningococcus: Dynamics of carriage and disease. Lancet, 1999, 353, 941-942.
56. Takala AK, Santosham M, Almeido-Hill J, Wolff M, Newcomer W et al.- Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J, 1993, 12, 593-599.
57. Varaine F, Caugant DA, Riou JY, Kondé MK, Soga G et al.- Meningitidis outbreaks and vaccination strategy. Trans R Soc Trop Med Hyg, 1997, 91, 3-7.
58. Wahdan MH, Sallam SA, Hassan MN, Abdel Gawad A, Rakha AS et al.- A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bull OMS, 1977, 55, 645-651.
59. WHO - Lutte Contre les Épidémies de Méningite ä Méningocoque. Guide Pratique de l'OMS. Fondation Marcel Mérieux Ed, Lyon, France, 1995, 72 p.
60. WHO - Response to epidemic meningitis in Africa. Week Epidemiol Rec, 1997, 72, 313-317.
61. WHO - Détecter une épidémie de méningite à méningocoque dans un pays à forte endémicité en Afrique. Recommandations de l'OMS. Week Epidemiol Rec, 2000, 75, 306-309.
62. WHO - Meningococcal disease, serogroup W135 (update). Week Epidemiol Rec, 2001, 76, 157.
63. WHO - Meningococcal disease, serogroup W135 (update). Week Epidemiol Rec, 2001, 76, 213-214.
64. Woods CW, Amstrong G, Sackey SO, Tetteh C, Bugri S et al.- Emergency vaccination against epidemic meningitis in Ghana: Implications for the control of meningococcal disease in west Africa. Lancet, 2000, 355, 30-33.
65. Woods CW, Sackey SO, Bugri S, Perkins BA & Rosenstein NE - Control of meningococcal disease in west Africa. Lancet, 2000, 355, 1185.
66. Zangwill KM, Stout RW, Carlone GM, Pais L, Harekeh H et al.- Duration of antiboy response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis, 1994, 169, 847-852.
67. Zhang Q, Choo S, Everard J, Jennings R & Finn A - Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun, 2000, 68, 2692-2697.